Healio11 小时
Direct-to-consumer genetic testing for cancer predisposition can have ‘pitfalls’
Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $22.00 Average Target Price from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus recommendation of “Hold” from the fourteen analysts that are covering the company, MarketBeat reports. Three ...
News Medical1 天
PAC-MANN blood test could help detect pancreatic cancer at early stages
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...
Craig-Hallum bulish on Myriad Genetics, initiates with a Buy
As previously reported, Craig-Hallum initiated coverage of Myriad Genetics (MYGN) with a Buy rating and $29 price target. The firm believes the ...